相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cytochromes P450 Catalyze Both Steps of the Major Pathway of Clopidogrel Bioactivation, whereas Paraoxonase Catalyzes the Formation of a Minor Thiol Metabolite Isomer
Patrick M. Dansette et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2012)
Crystal Structure of Human Cytochrome P450 2D6 with Prinomastat Bound
An Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Human Cytochromes P450: Focus on Cytochrome P450 2C19
Tatyana Zvyaga et al.
DRUG METABOLISM AND DISPOSITION (2012)
Effects of Omeprazole and Genetic Polymorphism of CYP2C19 on the Clopidogrel Active Metabolite
Xavier Boulenc et al.
DRUG METABOLISM AND DISPOSITION (2012)
Evaluation of the Effects of 20 Nonsynonymous Single Nucleotide Polymorphisms of CYP2C19 on S-Mephenytoin 4′-Hydroxylation and Omeprazole 5′-Hydroxylation
Huijuan Wang et al.
DRUG METABOLISM AND DISPOSITION (2011)
MolProbity: all-atom structure validation for macromolecular crystallography
Vincent B. Chen et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)
Protective effect of the CYP2C19*17 polymorphism with increased activation of clopidogrel on cardiovascular events
Klaus A. Tiroch et al.
AMERICAN HEART JOURNAL (2010)
Pharmacogenetic biomarkers as tools for improved drug therapy; emphasis on the cytochrome P450 system
Magnus Ingelman-Sundberg et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Cytochrome 2C19*17 Allelic Variant, Platelet Aggregation, Bleeding Events, and Stent Thrombosis in Clopidogrel-Treated Patients With Coronary Stent Placement
Dirk Sibbing et al.
CIRCULATION (2010)
Identification of the Human Cytochrome P450 Enzymes Involved in the Two Oxidative Steps in the Bioactivation of Clopidogrel to Its Pharmacologically Active Metabolite
Miho Kazui et al.
DRUG METABOLISM AND DISPOSITION (2010)
Metabolic Oxidative Cleavage of Thioesters: Evidence for the Formation of Sulfenic Acid Intermediates in the Bioactivation of the Antithrombotic Prodrugs Ticlopidine and Clopidogrel
Patrick M. Dansette et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2009)
CYP2C9 Amino Acid Residues Influencing Phenytoin Turnover and Metabolite Regio- and Stereochemistry
Carrie M. Mosher et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Genetic Determinants of Response to Clopidogrel and Cardiovascular Events.
Tabassome Simon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Comparison of mechanism-based inhibition of human cytochrome P450 2C19 by ticlopidine, clopidogrel, and prasugrel
Y. Nishiya et al.
XENOBIOTICA (2009)
Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation
Ulrich M. Zanger et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2008)
Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: An update
Edoardo Spina et al.
CLINICAL THERAPEUTICS (2008)
Proton pump inhibitors: an update of their clinical use and pharmacokinetics
Shaojun Shi et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Important amino acid residues that confer CYP2C19 selective activity to CYP2C9
Yasunobu Wada et al.
JOURNAL OF BIOCHEMISTRY (2008)
Determinants of cytochrome P4502C8 substrate binding -: Structures of complexes with montelukast, troglitazone, felodipine, and 9-cis-retinoic acid
Guillaume A. Schoch et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Influence of cytochrome P450 polymorphisms on drug therapies: Pharmacogenetic, pharmacoepigenetic and clinical aspects
Magnus Ingelman-Sundberg et al.
PHARMACOLOGY & THERAPEUTICS (2007)
Adaptations for the oxidation of polycyclic aromatic hydrocarbons exhibited by the structure of human P450 1A2
Stefaan Sansen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Scaling and assessment of data quality
P Evans
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2006)
Likelihood-enhanced fast translation functions
AJ McCoy et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2005)
Differential roles of Arg97, Asp293, and Arg108 in enzyme stability and substrate specificity of CYP2C9
LJ Dickmann et al.
MOLECULAR PHARMACOLOGY (2004)
Structure of human microsomal cytochrome P4502C8 - Evidence for a peripheral fatty acid binding site
GA Schoch et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The structure of human cytochrome P4502C9 complexed with flurbiprofen at 2.0-Å resolution
MR Wester et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Charge and substituent effects on affinity and metabolism of benzbromarone-based CYP2C19 inhibitors
CW Locuson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Coot:: model-building tools for molecular graphics
P Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)
Structure of mammalian cytochrome P4502C5 complexed with diclofenac at 2.1 Å resolution:: Evidence for an induced fit model of substrate binding
MR Wester et al.
BIOCHEMISTRY (2003)
Crystal structure of human cytochrome P4502C9 with bound warfarin
PA Williams et al.
NATURE (2003)
A new class of CYP2C9 inhibitors: Probing 2C9 specificity with high-affinity benzbromarone derivatives
CW Locuson et al.
DRUG METABOLISM AND DISPOSITION (2003)
Structure of a substrate complex of mammalian cytochrome P4502C5 at 2.3 Å resolution:: Evidence for multiple substrate binding modes
MR Wester et al.
BIOCHEMISTRY (2003)
Identification and functional characterization of new potentially defective alleles of human CYP2C19
J Blaisdell et al.
PHARMACOGENETICS (2002)
Identification of human CYP2C19 residues that confer S-mephenytoin 4′-hydroxylation activity to CYP2C9
CC Tsao et al.
BIOCHEMISTRY (2001)
Arginines 97 and 108 in CYP2C9 are important determinants of the catalytic function
M Ridderström et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Engineering microsomal cytochrome P4502C5 to be a soluble, monomeric enzyme - Mutations that alter aggregation, phospholipid dependence of catalysis, and membrane binding
J Cosme et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
